Drug recalls
Every medicine recall reported to the FDA since 2012, newest first. Last checked for new ones 15 hours ago.
23 recalls
- Class II Lillow (Levonorgestrel and Ethinyl Estradiol Tablets, USP), 0.15 mg/0.03 mg, 1 Blister Pack Containing 28 Tablets, Rx only, Distributed by: Amneal Pharmaceutica… CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions. Cardinal Healthcare · Jan 3, 2024 · Terminated
- Class II MY CHOICE LEVONORGESTREL TABLET distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022. CGMP Deviations: product held outside appropriate storage temperature conditions. Family Dollar Stores, Llc. · Aug 31, 2022 · Ongoing
- Class II Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.05mg/0.03 mg, 0.075mg/0.04mg, and 0.125mg/0.03mg, packaged in 1 Wallet of 28 Tablets (NDC 68180-857-11), 3 W… Failed Content Uniformity Specifications: Out Of Specification test results observed for content uniformity. Lupin Pharmaceuticals Inc. · Mar 18, 2020 · Terminated
- Class II Fayosim (levonorgestrel and ethinyl estradiol) tablets USP, (0.15 mg/0.02 mg, 0.15 mg/0.025 mg, 0.15 mg/0.03 mg) and ethinyl estradiol tablets USP, (0.01 mg), p… Failed Impurities/Degradation Specifications: Out-of-specification results observed in related substance test (Any Other Individual Impurity and Total impuritie… Lupin Pharmaceuticals Inc. · Apr 3, 2019 · Terminated
- Class III Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg, Rx Only, 3 extended-cycle blister packs containing 91 tablets each, Made in India, Manufactur… Labeling: Not Elsewhere Classified-Incorrect NDC and product name identified on blister packs. Mylan Pharmaceuticals Inc. · Oct 24, 2018 · Terminated
- Class III Altavera Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg and 0.03 mg, Rx only, 3 tablet dispensers x 28 tablets. Labeling: Not Elsewhere Classified: mislabeling of the Altavera generic name on the packaging component that may cause confusion. Xiromed LLC · Oct 17, 2018 · Terminated
- Class II My Way (levonorgestrel) Tablets TWO PACK, 1.5 mg each, packaged as 2 Treatments (Two 1.5mg Levonorgestrel Tablets) per carton, Manufactured for: Lupin Pharmaceu… Marketed Without an Approved NDA/ANDA: 2-pack configuration did not receive appropriate regulatory approval prior to release. Lupin Pharmaceuticals Inc. · May 30, 2018 · Terminated
- Class II My Way (Levonorgestrel) Tablets TWO PACK, 1.5 mg each, packaged as 2 Treatments (Two 1.5mg Levonorgestrel Tablets) per carton, GAVIS Pharmaceuticals, A Lupin Gr… Marketed Without an Approved NDA/ANDA: 2-pack configuration did not receive appropriate regulatory approval prior to release. Lupin Pharmaceuticals Inc. · May 30, 2018 · Terminated
- Class II Amethyst (Levonorgestrel and Ethinyl Estradiol Tablets USP, 90mcg/20mcg), 28 tablet dispenser (blister foil unit), Rx only, Manufactured by: Warner Chilcott Com… Labeling: Incorrect Instructions. "TABLETS IN WEEK 4 ARE INACTIVE" printed on the blister foil and package insert, however,all tablets are active. Teva Pharmaceuticals USA · Dec 27, 2017 · Terminated
- Class II Option 2, Levonorgestrel Tablet, 1.5 mg, Emergency Contraceptive, 1 Tablet per box, Distributed By Perrigo, Allegan, MI 49010. NDC 0113-2003-12 Defective Container: Carton is missing the tablet blister strip and tablet. L. Perrigo Company · Jun 14, 2017 · Terminated
- Class II Levonorgestrel, U.S.P. active pharmaceutical ingredient, packaged in 1 kg container, Rx only, Spectrum Chemical Mfg. CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer fo… Spectrum Laboratory Products, Inc. · Jun 14, 2017 · Terminated
- Class II Levonorgestrel Non-Micronized, USP, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qinhuangdao 066004,… cGMP Deviations; lack of quality assurance. Qinhuangdao Zizhu Pharmaceutical, Co. · Apr 19, 2017 · Terminated
- Class III Lutera (0.1 mg levonorgestrel and 0.02 mg ethinyl estradiol tablets USP), 28 day Regimen, 6 Tablet Dispensers per box, 28 Tablets Each, Rx Only, Manufactured fo… Labeling: Incorrect or Missing Package Insert; Product is being recalled because the birth control packs were distributed with out-dated package inserts. Actavis Inc · Jul 1, 2015 · Terminated
- Class II Next Choice" One Dose Emergency Contraceptive (Levonorgestrel Tablet), 1.5 mg, 1 Tablet/Blister Card (NDC 52544-287-54), Manufactured by Watson Laboratories Inc… Failed Tablet/Capsule Specifications: Multiple complaints for push through tablet breakage. Watson Laboratories Inc · Oct 16, 2013 · Terminated
- Class III Introvale (levonorgestrel and ethinyl estradiol) tablets, USP, 0.15 mg/0.03 mg, packaged in 91 day regimen per unit carton, 3 Unit Cartons x 91 tablets per box,… Contraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP 0.15mg/0.03mg) is volu… Sandoz Incorporated · Aug 14, 2013 · Terminated
- Class III Jolessa(R) (levonorgestrel/ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, 91 day regimen, Rx only, Manufactured by Barr Laboratories, Inc., Pomona, NY, manufa… Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing Teva Pharmaceuticals USA, Inc. · Jul 17, 2013 · Terminated
- Class III Lessina(R) (Levonorgestrel and ethinyl estradiol tablets, USP) 0.1 mg/0.02 mg, 28 day regimen, Rx only, Barr Laboratories Inc., Pomona, NY --- NDC 0555-9014-67 Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing Teva Pharmaceuticals USA, Inc. · Jul 17, 2013 · Terminated
- Class III Camrese(TM) (Levonorgestrel/Ethinyl Estradiol Tablets), 0.15 mg/0.03 mg and Ethinyl Estradiol 0.01 Tablets, 2 Extended-Cycle Tablet Dispensers (NDC 0093-3134-82… Failed Impurity/Degradation Specifications; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing Teva Pharmaceuticals USA, Inc. · Jun 5, 2013 · Terminated
- Class III Seasonale(R) (Levonorgestrel/Ethinyl Estradiol Tablets), 0.15 mg/0.03 mg, 3 extended-cycle tablet dispensers, 91 tablets each, Rx only, TEVA Women Health, Inc.,… Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing Teva Pharmaceuticals USA, Inc. · Jun 5, 2013 · Terminated
- Class III Jolessa (levonorgestrel/ethinyl estradiol) Tablets, 0.15 mg/0.03 mg, 91-count tablets per extended-cycle tablet dispenser packaged in 3 dispensers per carton, R… Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance. Teva Pharmaceuticals USA, Inc. · Apr 17, 2013 · Terminated